{
    "2020-11-10": [
        [
            {
                "time": "2020-11-09",
                "original_text": "'We're in a critical period right now': Infectious Disease Physician on current state of COVID-19 in the U.S.",
                "features": {
                    "keywords": [
                        "critical period",
                        "COVID-19",
                        "U.S."
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-10",
                "original_text": "'It would be devastating': Former Obama advisor Valerie Jarrett on possibility of the Supreme Court overturning the Affordable Care Act",
                "features": {
                    "keywords": [
                        "devastating",
                        "Affordable Care Act",
                        "Supreme Court"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-11",
                "original_text": "Why Eli Lilly's Coronavirus Drug Authorization Is Bad News For A Key Rival",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Coronavirus Drug",
                        "Authorization"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-12",
                "original_text": "Stock Market Today: Growth Takes a Backseat to Value Yet Again",
                "features": {
                    "keywords": [
                        "Stock Market",
                        "Growth",
                        "Value"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-13",
                "original_text": "Jim Cramer on the Search for Stock-Buying Opportunities Tuesday",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Stock-Buying",
                        "Opportunities"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-14",
                "original_text": "Doctor: Vaccine availability will be a 'valuable asset in this fight against COVID-19'",
                "features": {
                    "keywords": [
                        "Vaccine",
                        "availability",
                        "valuable asset",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-15",
                "original_text": "U.S. to start distributing Lilly COVID-19 antibody this week",
                "features": {
                    "keywords": [
                        "U.S.",
                        "distributing",
                        "Lilly",
                        "COVID-19",
                        "antibody"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "Dow Jones Leads Mixed Market As Covid Vaccine Hopes Slam Tech Stocks Again",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Mixed Market",
                        "Covid Vaccine",
                        "Tech Stocks"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "market",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}